Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines

British Journal of Haematology

Volumn 126, Issue 5, 2004, Pages 726-735

  Watanabe, Dai ^a   Ezoe, Sachiko ^b   Fujimoto, Minoru ^a   Kimura, Akihiro ^a   Saito, Yoshiyuki ^a   Nagai, Hisaki ^c   Tachibana, Isao ^a   Matsumura, Itaru ^b   Tanaka, Toshio ^a   Kanegane, Hirokazu ^d   Miyawaki, Toshio ^d   Emi, Mitsuru ^c   Kanakura, Yuzuru ^b   Kawase, Ichiro ^a   Naka, Tetsuji ^a   Kishimoto, Tadamitsu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Acute myeloid leukaemia; Janus family tyrosine kinases; Methylation; Suppressor of cytokine signalling 1; Tumour suppressor

Indexed keywords

JANUS KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ARTICLE; BLOOD LEVEL; CELL GROWTH; CONTROLLED STUDY; DNA METHYLATION; GENE SILENCING; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MYELOID LEUKEMIA; PRIORITY JOURNAL;

ACUTE DISEASE; CARRIER PROTEINS; CELL LINE; CELL LINE, TUMOR; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; LEUKEMIA, MYELOID; METHYLATION; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 4544358147     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05107.x     Document Type: Article

References (47)

1. Alexander, W.S. (2002) Suppressors of cytokine signalling (SOCS) in the immune system. Nature Reviews in Immunology, 2, 410-416.
2. Alexander, W.S., Starr, R., Fenner, J.E., Scott, C.L., Handman, E., Sprigg, N.S., Corbin, J.E., Cornish, A.L., Darwiche, R., Owczarek, C.M., Kay, T.W., Nicola, N.A., Hertzog, P.J., Metcalf, D. & Hilton, D.J. (1999) SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell, 98, 597-608.
3. Baylin, S.B., Esteller, M., Rountree, M.R., Bachman, K.E., Schuebel, K. & Herman, J.G. (2001) Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Human Molecular Genetics, 10, 687-692.
4. Boocock, G.R., Morrison, J.A., Popovic, M., Richards, N., Ellis, L., Durie, P.R. & Rommens, J.M. (2003) Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nature Genetics, 33, 97-101.
5. Chen, C.Y., Tsay, W., Tang, J.L., Shen, H.L., Lin, S.W., Huang, S.Y., Yao, M., Chen, Y.C., Shen, M.C., Wang, C.H. & Tien, H.F. (2003) SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia. Genes Chromosomes Cancer, 37, 300-305.
6. Croker, B.A., Krebs, D.L., Zhang, J.G., Wormald, S., Willson, T.A., Stanley, E.G., Robb, L., Greenhalgh, C.J., Forster, I., Clausen, B.E., Nicola, N.A., Metcalf, D., Hilton, D.J., Roberts, A.W. & Alexander, W.S. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Natural Immunology, 4, 540-545.
7. De Sepulveda, P., Okkenhaug, K., Rose, J.L., Hawley, R.G., Dubreuil, P. & Rottapel, R. (1999) Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. EMBO Journal, 18, 904-915.
8. Depil, S., Saudemont, A. & Quesnel, B. (2003) SOCS-1 gene methylation is frequent but does not appear to have prognostic value in patients with multiple myeloma. Leukemia, 17, 1678-1679.
9. Dong, F., Hoefsloot, L.H., Schelen, A.M., Broeders, C.A., Meijer, Y., Veerman, A.J., Touw, I.P. & Lowenberg, B. (1994) Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proceedings of the Natational Academy of Sciences of the United States of America, 91, 4480-4484.
10. Ferguson, A.T., Lapidus, R.G. & Davidson, N.E. (1998) Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression. Oncogene, 17, 577-583.
11. Fujimoto, M. & Naka, T. (2003) Regulation of cytokine signaling by SOCS family molecules. Trends in Immunology, 24, 659-666.
12. Fujimoto, M., Tsutsui, H., Yumikura-Futatsugi, S., Ueda, H., Xingshou, O., Abe, T., Kawase, I., Nakanishi, K., Kishimoto, T. & Naka, T. (2002) A regulatory role for suppressor of cytokine signaling-1 in T(h) polarization in vivo. International Immunology, 14, 1343-1350.
13. Fujimoto, M., Tsutsui, H., Xinshou, O., Tokumoto, M., Watanabe, D., Shima, Y., Yoshimoto, T., Hirakata, H., Kawase, I., Nakanishi, K., Kishimoto, T. & Naka, T. (2004) Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. International Immunology, 16, 303-314.
14. Fukushima, N., Sato, N., Sahin, F., Su, G.H., Hruban, R.H. & Goggins, M. (2003) Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. British Journal of Cancer, 89, 338-343.
15. Galm, O., Yoshikawa, H., Esteller, M., Osieka, R. & Herman, J.G. (2003) SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood, 101, 2784-2788.
16. Hanada, T., Yoshida, T., Kinjyo, I., Minoguchi, S., Yasukawa, H., Kato, S., Mimata, H., Nomura, Y., Seki, Y., Kubo, M. & Yoshimura, A. (2001) A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box. Journal of Biological Chemistry, 276, 40746-40754.
17. Harrison, D.A., Binari, R., Nahreini, T.S., Gilman, M. & Perrimon, N. (1995) Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO Journal, 14, 2857-2865.
18. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proceedings of the National Academy of Sciences of the United States of America, 93, 9821-9826.
19. Kamizono, S., Hanada, T., Yasukawa, H., Minoguchi, S., Kato, R., Minoguchi, M., Hattori, K., Hatakeyama, S., Yada, M., Morita, S., Kitamura, T., Kato, H., Nakayama, K. & Yoshimura, A. (2001) The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. Journal of Biological Chemistry, 276, 12530-12538.
20. Kile, B.T., Schulman, B.A., Alexander, W.S., Nicola, N.A., Martin, H.M. & Hilton, D.J. (2002) The SOCS box: a tale of destruction and degradation. Trends in Biochemical Sciences, 27, 235-241.
21. Kishida, T., Stackhouse, T.M., Chen, F., Lerman, M.I. & Zbar, B. (1995) Cellular proteins that bind the von Hippel- Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Research, 55, 4544-4548.
22. Lacronique, V., Boureux, A., Valle, V.D., Poirel, H., Quang, C.T., Mauchauffe, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J. & Bernard, O.A. (1997) A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science, 278, 1309-1312.
23. Lacronique, V., Boureux, A., Monni, R., Dumon, S., Mauchauffe, M., Mayeux, P., Gouilleux, F., Berger, R., Gisselbrecht, S., Ghysdael, J. & Bernard, O.A. (2000) Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood, 95, 2076-2083.
24. Lang, R., Pauleau, A.L., Parganas, E., Takahashi, Y., Mages, J., Ihle, J.N., Rutschman, R. & Murray, P.J. (2003) SOCS3 regulates the plasticity of gp130 signaling. Natural Immunology, 4, 546-550.
25. Lin, S.Y., Yeh, K.T., Chen, W.T., Chen, H.C., Chen, S.T., Chiou, H.Y. & Chang, J.G. (2004) Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. Oncology Reports, 11, 341-348.
26. Liu, T.C., Lin, S.F., Chang, J.G., Yang, M.Y., Hung, S.Y. & Chang, C.S. (2003) Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia. British Journal of Haematology, 123, 654-661.
27. Luo, H., Hanratty, W.P. & Dearolf, C.R. (1995) An amino acid substitution in the Drosophila hopTum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO Journal, 14, 1412-1420.
28. Marine, J.C., Topham, D.J., McKay, C., Wang, D., Parganas, E., Stravopodis, D., Yoshimura, A. & Ihle, J.N. (1999) SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell, 98, 609-616.
29. Metcalf, D., Alexander, W.S., Elefanty, A.G., Nicola, N.A., Hilton, D.J., Starr, R., Mifsud, S. & Di Rago, L. (1999) Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1. Leukemia, 13, 926-934.
30. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J.S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A. & Roifman, C.M. (1996) Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature, 379, 645-648.
31. Migone, T.S., Lin, J.X., Cereseto, A., Mulloy, J.C., O'Shea, J.J., Franchini, G. & Leonard, W.J. (1995) Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science, 269, 79-81.
32. Nagai, H., Kim, Y.S., Lee, K.T., Chu, M.Y., Konishi, N., Fujimoto, J., Baba, M., Matsubara, K. & Emi, M. (2001) Inactivation of SSI-1, a JAK/STAT inhibitor, in human hepatocellular carcinomas, as revealed by two-dimensional electrophoresis. Journal of Hepatology, 34, 416-421.
33. Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y., Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama, Y. & Kishimoto, T. (1998) Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 95, 15577-15582.
34. Narazaki, M., Fujimoto, M., Matsumoto, T., Morita, Y., Saito, H., Kajita, T., Yoshizaki, K., Naka, T. & Kishimoto, T. (1998) Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proceedings of the National Academy of Sciences of the United States of America, 95, 13130-13134.
35. Nicholson, S.E., Willson, T.A., Farley, A., Starr, R., Zhang, J.G., Baca, M., Alexander, W.S., Metcalf, D., Hilton, D.J. & Nicola, N.A. (1999) Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO Journal, 18, 375-385.
36. O'Shea, J.J., Gadina, M. & Schreiber, R.D. (2002) Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell, 109(suppl.), 121-131.
37. Peeters, P., Raynaud, S.D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Van Rompaey, L., Baens, M., Van den Berghe, H. & Marynen, P. (1997) Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood, 90, 2535-2540.
38. Rottapel, R., Ilangumaran, S., Neale, C., La Rose, J., Ho, J.M., Nguyen, M.H., Barber, D., Dubreuil, P. & de Sepulveda, P. (2002) The tumor suppressor activity of SOCS-1. Oncogene, 21, 4351-4362.
39. Saito, H., Morita, Y., Fujimoto, M., Narazaki, M., Naka, T. & Kishimoto, T. (2000) IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-gamma. Journal of Immunology, 164, 5833-5843.
40. Schwaller, J., Frantsve, J., Aster, J., Williams, I.R., Tomasson, M.H., Ross, T.S., Peeters, P., Van Rompaey, L., Van Etten, R.A., Ilaria, R. Jr., Marynen, P. & Gilliland, D.G. (1998) Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO Journal, 17, 5321-5333.
41. Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jenkins, B.J., Gonda, T.J., Alexander, W.S., Metcalf, D., Nicola, N.A. & Hilton, D.J. (1997) A family of cytokine-inducible inhibitors of signalling. Nature, 387, 917-921.
42. Starr, R., Metcalf, D., Elefanty, A.G., Brysha, M., Willson, T.A., Nicola, N.A., Hilton, D.J. & Alexander, W.S. (1998) Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proceedings of the National Academy of Sciences of the United States of America, 95, 14395-14399.
43. Watanabe, D., Hashimoto, S., Ishiai, M., Matsushita, M., Baba, Y., Kishimoto, T., Kurosaki, T. & Tsukada, S. (2001) Four tyrosine residues in phospholipase C-gamma 2, identified as Btk- dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium signaling. Journal of Biological Chemistry, 276, 38595-38601.
44. Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., Hirano, T., Chien, K.R. & Yoshimura, A. (2003) IL-6 induces an antiinflammatory response in the absence of SOCS3 in macrophages. Nature Immunology, 4, 551-556.
45. Yoshikawa, H., Matsubara, K., Qian, G.S., Jackson, P., Groopman, J.D., Manning, J.E., Harris, C.C. & Herman, J.G. (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nature Genetics, 28, 29-35.
46. Yoshimura, A., Mori, H., Ohishi, M., Aki, D. & Hanada, T. (2003) Negative regulation of cytokine signaling influences inflammation. Current Opinion in Immunology, 15, 704-708.
47. Zhang, Q., Nowak, I., Vonderheid, E.C., Rook, A.H., Kadin, M.E., Nowell, P.C., Shaw, L.M. & Wasik, M.A. (1996) Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proceedings of the National Academy of Sciences of the United States of America, 93, 9148-9153.